Académique Documents
Professionnel Documents
Culture Documents
Palliative Medicine-Dauwalder
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
Confusional States
1. Delirium-disturbed consciousness, cognition over a short time (DSM-IV)
a. AKA acute confusional state, acute mental status change, altered mental status
b. Significant increase in hospital death, nosocomial complications, and poor functional recovery
c. DDX-depression, Werrnicke-Korsakoff, HIV, Neurosyphilis, Vit B12 deficiency, normal pressure hydrocephalus, Rx
SE, hyperthyroidism, subdural hematoma
d. Delirium is often not recognized by physicians/nurses
e. Confusion Assessment Method (CAM) allows Dx with high sensitivity and specificity
i. Requires acute change in mental status that fluctuates
Dementia-an acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert
pt.
a. Progressive, disabling, and NOT an inherent part of aging
i. Ex: not recognizing family, forgetting to serve just prepared meal, getting lost in own neighborhood
b. May occur along with delirium.
i. Alzheimers (MOST COMMON)-memory impairment, gradual onset, progressive, difficult learning new
things, aphasia, apraxia, agnosia, changed exutive function
ii. Not do to CNS/physical condition or Axis I d/o
c. Vascular (2nd MOST COMMON)-focal neuro sx and signs of cerebrovascular dz w/ the AD sxs (see above)
d. Lewy Bodies-visual hallucinations, Pakinsonian signs, attention/alertness changes
e. Family bears financial and emotional burden
i. Nearly half of caregivers suffer clinical depression
f. Risk factors-AGE, Fam Hx, head injury, less education (less coping mechanisms have developed)
g. Genetics
i. Chromosomes 1,14,21early onset (before 60)
ii. APOE*4 on chromosome 19late onset
1. APOE*2 may be protective allele
h. Protective factors-Estrogen replacement (post-menopausal pts), NSAIDS, AOs, physical activity
i.
j.
3.
3.
i. Referral for lack of utilities, poor hygiene, unsafe environment, cognitive disorders, questionable Rx
adherence, needed capacity evaluation
1. Possibly multiple reasons
e. Consequence of untreated medical dzs (hypothyroidism, DM, CA
i. Also health hazards in conditions
f. Limited access to tx or denial of tx (poor judgment ability)
g. Poor living conditions are not always easily apparent, so pts will be discharged back to unsafe conditions
h. Is very common (prevalence of 50.3% to 39.1% or higher)
i. Increasing awareness AND reports of self neglect
1. Demographic shift to more elders
- Qualify of life and economic consequences
i. Change in ability to pts and carry out taskscant take steps needed for appropriate self-care
j. It is wrong to impose medical or social remedies on eccentric elders who have capacity, but should not allow living
in extreme squalor (ex: no utilities)
k. There is not much evidence to guide intervention w/ APS
i. Public health, legal, medical, nursing problem to address
ii. Research has cost-containment potential and could improve overall quality of life for elderly pts
The ETHNIC(S) Mnemonic: A Clinical Tool for Ethnogeriatric Education
a. Large health disparities among older people from different racial and ethnic groups
b. Cultural competency involving awareness and acceptance of cultural difference, self-awareness, knowledge of pts
culture, and adaption of medical skills.
i. Training for this has been proposed at every level of healthcare professional training
c. Real-time availability of language services is important and remains problematic
d. Illness Explanatory model (EM)negotiate acceptable tx
i. LEARN-Listen, Explain, Acknowledge, Recommend, Negotiate
ii. BATHE-Background, Affect, Trouble, Handling, Empathy
iii. ESFT-Explanatory model, Social and environmental factors, Fears and concerns, Therapeutic contracting
e. ETHNIC-addresses cross-cultural healthcare in 15-minute visits in a variety of healthcare settings
i. EXPLANATION-Why do you think you have this?
1. What do others say about these sx?
2. Do you know anyone w/ this kind of problem?
3. What have you learned about this in the media?
4. What concerns you about this problem?
ii. TREATMENT-What have you tried for this?
1. Pt might only share what they think would be acceptable to the provider, so ask explicitly w/o
judgment
2. What do you eat/drink/do/avoid to stay healthy?
3. What tx are you seeking from me?
iii. HEALERS-Who else have you sought help from for this?
1. Have you consulted alternative/folk healers, friends, other non-doctors?
iv. NEGOTIATE-How best do you think I can help you?
1. Find options that are mutually acceptable and incorporate pts beliefs
- Try to not contradict pt beliefs
2. Focus on functional outcomes and sx relief
v. -NTERVENTION-This is what I think needs to be done now
1. May also incorporate alternative tx, spirituality, healers, and cultural practices
vi. COLLABORATE-How can we work together on this?
1. Who else can we work with?
- Family members, healers, community resources
vii. SPIRITUALITY SENIORS-What role does faith, religion, spirituality plays in helping you with this?
1. What is your spiritual life like?
2. Can be very effective as establishing trust/rapport
f. ETHNIC is not a scoring sheet nor detection scheme, but a tool for eliciting and negotiating cultural issues during
healthcare encounters
i. Does not address a lot of other barriers like sensory disabilities, discrimination, and bias.
g. It is important to avoid stereotyping, maintain respectful communication, and foster empowerment in
relationships w/ elderly pts
4.
Geriatric Pharmacology
a. Individuals 65 and older are leading consumers of medications
i. Might herbals/OTC or Rx
ii. More are taken in nursing homes (9 avg) than community (4 avg)
b. #1 reason for nursing home admittance is urinary incontinence
c. More doctors, more prescription errors
i. Error is they are allergic (looking at algorithm, not pt)
ii. Error is the wrong dose
d. Any sx in an elderly pt should be considered a drug SE until proven otherwise
i. An easy fix
e. Noncompliancemedication related problemsmajor health care costs
f. Elderly at greater risk for medication problems
i. Multiple chronic diseases
ii. Multiple Prescribers (lack of geriatric trained)
iii. Multiple medications, types
g. Aging changes the special senses, oral health (dry mouthinfection), CV, GI (hypochlordydriahigher pH and
constipation), and metabolism
h. Aging affects pharmacokinetics
i. Decreased 1st pass effectmore bioavailable in plasmamore SEs
ii. More keratinized skin, less skin lipids/circulation/hydration decreased absorption from transdermal
patch
iii. Slow GI, less blood flow, higher gastric pHdelayed onset/peak but NO change in quantity absorbed.
iv. Less m. mass and blood flow, more CTless IM absorption
v. Less body water, more body fat (think about lipo/hydrophilic Rx
vi. Less albuminless Rx bindingmore free Rxmore SE
1. Have to decrease Ca doseavoid kidney stones/CV problems
vii. Have less liver mass/blood flowless phase-I metabolismless clearance and longer H/L
1. Phase II metabolism and CYP 450 activity are unchanged
- CYP 2D6 increases w/ age (2 even numbers=more)
- CYP 1A2, CYP 2C19 decrease (1 odd, 1 even=less)
viii. Lifestyle can induce/inhibit enzymes (Smoking/ETOH/Drugs/etc)
1. Hx is important, change dosing
ix. Creatnine clearance is an important measure of physiologic changes that need to be accounted for w/
doseprevent toxicity
x. -CrCl decreases starting at 25yo (50% by 85)
i. Aging affects pharmacodynamics
i. Increased receptor sensitivity to benzos, warfarin, opioids
ii. Decreased receptor sensitivity to beta blockers
iii. Decreased baroreceptor sensitivity
1. Ortho HoTN w/ vasodilators, tricyclic anti-depress, BP meds
iv. Antipsychotics are NOT tx for dementia
v. Decreased renin/ALD levelsmore risk for hyperkalemia
j. No apparent pharmacogenomics issues in terms of changes as adults
Ethnicity plays a role in speed of metabolizing Rxs
k. Clinical response=Pharmacokinetics + Pharmacodynamics + Individual Variance
i. Interpatient variability makes it difficult
1. Dz, nutrition, adherence, other meds
l. Non-adherence from not filling Rx, used not as intended
i. Costincreases/decrease use (cant pay, use if perceived as better b/c expensive)
ii. From dementia, cant read, in denial, cant open containers, too large to swallow, complicated regimens,
dont understand instructions
m. Avoid using another medication to tx a SE of another agent
n. Adverse effects
i. Most commonly confusion, cognitive impairment, falls, GI probs
1. benzosfalls
ii. Anticholinergic Effects: Cant see, spit, pee, and poop
iii. The Beers Criteria-criteria for determining meds bad for elderly
1. High Severity=adverse outcome likely, clinically significant
2.
3.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
Fall Prevention
1. Falls are the leading cause of death and disability in the elderly
a. Small % die, large % go to EDlots of cost
b. Downward spiral from fall injury
2.
3.
4.
Osteoporosis
1. Fallsfracturesincreased mortality-20% (esp hip fx)
2. Most common osteoporotic fx=vertebral
3. Most devastating osteoporotic fx=hip
4. Measuring BMD
5. Risk Factors
a. BMD, age, prior fxstrongest predictors of fracture risk
b. Also glucocorticoid therapy, fam hx (1st degree relative), low BMI, cigarette smoking (esp currently), excessive
ETOH
c. RA, Lupus, IBD, Celiac, bariatric surg, CF, Hyperthyroidism, Hyperparathyroidism, DM, RD, Leukemia, Lymphoma,
Multiple Myeloma, PD, MS
6. Assessment-10 yr probability of major osteoporotic fx in untreated pt
a. T/Z-score and clinical risk
b. FRAX-T-score or total hip BMD
c. Measure BMD
i. Gold standard is Dual energy X-ray absorptiometry (DXA)
1. Not portable, expensive, low dose ionizing radiation
ii. Peripheral DXA (pDXA)-in forearm, calcaneus, finger
1.
Technical differences, variation in these bone regions, dont have stand reference database to
get T-scores
iii. Quantitative CT-measures volumetric BMD
1. Can isolate trabecular bone from cortical bone
2. -Less reproducible, higher radiation dose than DXA
d. Quantitative US
i. Does not measure BMD, but other parameters
ii. No studies showing reduced fx risk, cant measure tx response b/c changes are too slow
e. F/U BMD testing did not improve predictive value of fx risks
i. Interval testing-maybe some value, but only after 2 yrs
f. Bone turnover markers are associated, but varyconfounded use
7. Screening (BMD testing)
a. USPSTF recommends screen women older than 65 or younger w/ a risk equal to or greater than 65yo white
women w/ no additional risk factors
i. Younger postmenopausal women
ii. Men over 70yo
iii. Men over 50yo w/ that increased risk (ex: previous fx)
8. Prevention
a. Check for risks/causes
b. Advise Ca and Vit D
c. Regular weight bearing and muscle strengthening exercise
d. Avoid smoking and excessive ETOH
9. Treatment Recommended
a. Hip/vertebral fxs
b. T-score of -2.5 or more
c. Post-meno women or men over 50yo w/ T-score -1 to -2.5
d. FRAX greater than 3% risk
10. BMD AND clinical risk factors (together)best estimate of fx risk
11. Screen and tx early to reduce morbidity/mortality
Pressure Ulcers
1. Localized injury to skin/underlying tissue (pressure/shear)vascular inflow impairmentischemiatissue damage (decubitus
ulcers, bedsores, pressure sores)increased morbidity/mortality
a. Mostly elderly or younger pts w/ neuro impairment/severe illness
i. Common denominator=limited mobility
b. Higher the stagethe worse the healing within 6 mo
c. 2nd leading cause of litigation in long term care
2. #1 Sacrum, #2 Heels for areas of development
3. Intrinsic risk factors
a. Limited mobility
b. Poor Nutrition
c. Comorbidities-cognitive, CV, etc
d. Aging skin-thinner, drier, less elastic, w/ slow healing
4. Extrinsic risk factors
a. Pressure-hard surface
b. Friction-poor movement in bed
c. Shear-involuntary muscle movements
d. Moisture
5. Prevention
a. ID at-risk pts
b. Inspect skin daily
c. Wash with warm water (NOT hot)
d. Lubricate skin
e. Avoid bony prominence massage (added pressure, friction)
f. Reduce pressure-reposition, mattress overlays, heel protectors
i. Do NOT use donut cushions
g. Manage incontinence-reduce moisture
h. Positioning
6.
7.
Assessment
a. #, location, size, exudate (none/slight/moderate/copious and serous/serosanguinous/purulent), odor, necrosis,
infection, healing,
b. margins, sinus tracts, tunneling
c. Stage 1-non-blanchable redness over bony, compare elsewhere
i. Tx: protective dressing
d. Stage 2-shallow open ulcer (dermis lost) w/ red-pink wound or intact/ruptured blister
i. Tx: moist dressing, clean the wound
e. Stage 3-full thickness of skin lost, possibly exposing subcutaneous fat, may includes undermining and tunneling
i. Tx: most/absorbent dressing, surg consultation, clean at each dressing stage
f. Stage 4-exposed bone, tendon, or muscle, often includes undermining and tunneling
i. increased risk of osteomyelitis or osteitis
ii. Tx: same as stage 3
g. Unstageable if base of ulcer is covered by slough
i. Dont remove stable eschar
h. DO NOT REVERSE STAGE (once stage 4, always stage 4)
i. Keep original stage and add healing descriptors
Tx: clean, ABs (topical or systemic based on local or systemic infection)
a. DONT use antiseptic agents
i. They destroy granulation tissue
b. Debridement of necrotic tissue
i. For advancing cellulitis or sepsis
1. Sharp debridement: sterile scalpel or scissors
ii. Non-urgent
1. Mechanical debridement
2. Autolytic debridement
- complete wound healing not the main goal
3. Enzymatic debridement
4. Biological debridement: larval or maggot therapy
c. Transparent film: semi-permeable adhesive
i. not for infected or draining wounds
d. Hydrogel-fill dead space tissue w/ impregnated gauze, sooths pain, rehydrates wound bed, can be used w/
infected or deep wounds
i. Not for wounds w/ heavy exudate
e. Alginate-from brown seaweed absorbs a lot (heavy exudate)
i. Not for light exudate, dry, superficial woundsdehydrates
f. Foam-Nonadherent, absorbs exudate
i. Not for dry eschar
g. Hydrocolloid-semiocclusive dressing, facilitates autolytic debridement
i. Not for heavy exudate, sinus tracts, infection, packing
h. Moistened gauze-soaked in saline, but be remoistened often
i. Refer to specialists for skin flaps/grafts, wound vac, electromagnetic therapy, and vascular surgery
Choosing Wisely
1. More CA and CA deaths, CA acts differently in the elderly
a. Acute Myeloid Leukemia, ovarian CA, Non-Hodgkins Lymphoma have worse px
b. Breast CA has a more idle course
c. W/ CA screening, think about the pt, would they benefit?
d. Radiation is generally well-accepted in elderly
i. Caution w/ chemo-radiation
e. Age is not a contraindication of chemotherapy
i. Increased risks for myelosuppression, neuropathy, cardiac toxicity, mucositis, dehydration, electrolyte
abnormalities, malnutrition
1. Adjust dose or substitute drugs
2. Screen if
a. High prevalence, serious consequences, detectable preclinically, tx is better if applied before sxs
b. Tests should be simple, inexpensive, high sensitivity/specificity
3. Life expectancy-functional status AND comorbidities
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Colorectal CA
a. USPSTF-Screen all average-risk 50-75yos every 10yrs
i. Dont do routine screening 76-85yo
ii. Dont screen over 85yo
b. ACG 2008-colonoscopy every 10yrs start at 50yo (45 for AA)
i. If fam hx40yo or 10 yrs younger than youngest relative dx
Breast CA
a. USPSTF-every 2 yrs for women 50-74yrs
b. AGS-extends up to age 80
c. ACS and ACOG-every yr starting at 40yo
d. MRI is NOT recommended to screen w/ average risk pts
Cervical CA
a. Stop screening w/ 3 nml Paps in the last 10 yrs and pt over 65yo
Ovarian CA
a. Screen only w/ strong fam hx
b. Early sxsCa 125, TVUS (controversial)
Prostate CA
a. Screening indication is blurry (dont screen about 75yo though)
b. DRE for 50 yo (45 if fam hx, or AA pt)
Bladder CA
a. Evidence is insufficient to screen w/o sx
Lung CA
a. Screen w/ low-dose CT if 55-80yo and 30pk/yr smoking hx and currently smoke or quit within the last 15yrs
i. Discontinue if quitting date becomes more than 15yrs ago
DVT
a. Dont work up clotting disorder on 1st DVT episode
b. Dont repeat US DVT if no clinical change
Bacteriuria
a. No adverse outcomes w/ asymptomatic bacteriuria
Carotid A. Imaging
a. Focal neuro deficitsfainting (not occlusive a. dz)
Stress Cardiac Imaging
a. Dont perform w/o cardiac sx unless DM w/ pts over 40yo, PAD, greater than 2% yr risk for HD events
Low Back Pain
a. Dont do imaging for LBP within 6 wks unless red flags
i. severe/progressive neuro deficits, osteomyelitis
Sinusitis
a. Dont give AB unless sx 7 days or more
Feeding Issues
a. Dont recommend percutaneous feeding tubes w/ advanced dementia
i. Pressure ulcers, more restraints, no improvements
-End Stage Renal Dz
a. Chronic dialysis decision is an individual one (based on Px)